1. Abu-Ghanem, S., Oberkovitz, G., Benharroch, D., Gopas, J., & Livneh, E. (2007). PKCeta expression contributes to the resistance of Hodgkin’s lymphoma cell lines to apoptosis. Cancer Biology & Therapy, 6, 1375–1380.
2. Ahmad, S., & Glazer, R. I. (1993). Expression of the antisense cDNA for protein kinase C alpha attenuates resistance in doxorubicin-resistant MCF-7 breast carcinoma cells. Molecular Pharmacology, 43, 858–862.
3. Ahmad, S., Safa, A. R., & Glazer, R. I. (1994). Modulation of P-glycoprotein by protein kinase C alpha in a baculovirus expression system. Biochemistry, 33, 10313–10318.
4. Aquino, A., Hartman, K. D., Knode, M. C., Grant, S., Huang, K. P., Niu, C. H., et al. (1988). Role of protein kinase C in phosphorylation of vinculin in adriamycin-resistant HL-60 leukemia cells. Cancer Research, 48, 3324–3329.
5. Baldwin, R. M., Garratt-Lalonde, M., Parolin, D. A., Krzyzanowski, P. M., Andrade, M. A., & Lorimer, I. A. (2006). Protection of glioblastoma cells from cisplatin cytotoxicity via protein kinase Ciota-mediated attenuation of p38 MAP kinase signaling. Oncogene, 25, 2909–2919.